FREECAP
Collaborators
Professor Andrew Carr (NDORMS)
Professor Chris Buckley (NDORMS)
Professor Jonathan Rees (NDORMS)
Mr Stephen Gwilym (NDORMS)
Mr Christopher Little (NDORMS)
Professor Amar Rangan (NDORMS)
Mr Andrew Titchener (NDORMS)
Professor Kim Midwood (NDORMS)
Professor Jesmond Dalli (QMUL)
Professor Derek Gilroy (UCL)
Professor Michael Kjaer (Copenhagen)
Professor Andreas Traweger (PMU)
Professor Paul Klenerman (Peter Medawar)
Professor Adam Croft (Birmingham)
Professor Alayna Loiselle (Rochester)
Key Publications
Inflammation activation and resolution in human tendon disease.
Journal article
Dakin SG. et al, (2015), Sci Transl Med, 7
Pathogenic stromal cells as therapeutic targets in joint inflammation.
Journal article
Dakin SG. et al, (2018), Nat Rev Rheumatol, 14, 714 - 726
15-Epi-LXA4 and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture.
Journal article
Dakin SG. et al, (2019), FASEB J, 33, 8043 - 8054
Tissue inflammation signatures point towards resolution in adhesive capsulitis.
Journal article
Dakin SG. et al, (2019), Rheumatology (Oxford), 58, 1109 - 1111
Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy.
Journal article
Dakin SG. et al, (2017), Sci Rep, 7
Persistent stromal fibroblast activation is present in chronic tendinopathy.
Journal article
Dakin SG. et al, (2017), Arthritis Res Ther, 19
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution.
Journal article
Ng MTH. et al, (2024), Nat Commun, 15
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases
Journal article
Johnson PA. et al, (2023), The Lancet Rheumatology, 5, e553 - e563
Chronic inflammation is a feature of Achilles tendinopathy and rupture.
Journal article
Dakin SG. et al, (2018), Br J Sports Med, 52, 359 - 367
In this section
- Centre for Rehabilitation Research in Oxford
- Oxford Orthopaedic Engineering Centre
- Centre for Statistics in Medicine
- Oxford Clinical Trials Research Unit
- Edwards Group | Bone Oncology
- Oppermann Group | Epigenetic Mechanisms in Musculoskeletal Disease
- Price Group | Knee Research Group
- Glyn-Jones Group | Hip Research Group
- Lavy Group | Global Surgery
- Luqmani Group | Vasculitis and GCA
- Bowness Group | Immunology of Ankylosing Spondylitis
- Rees Group | Shoulder Research and Delivery of Orthopaedic Treatments
- Hulley Group | Integrated musculoskeletal tissue modelling
- Furniss Group | Genetics and Epidemiology of Common Hand Conditions
- Edwards Group | Musculoskeletal Ageing
- EQUATOR Centre UK
- Jain Group | Outcome Studies and Translational Research in Musculoskeletal Surgery
- Midwood Group | Matrix Immunology
- Vincent Group | Molecular Pathogenesis of Osteoarthritis
- Udalova Group | Genomics of Inflammation
- Williams Group | Targeting Disease Pathways in Rheumatoid Arthritis
- Itoh Group | Cell Migration
- Centre for Sport, Exercise and Osteoarthritis
- Arnon Group | Lymphocyte Trafficking and Adaptive Immunity
- Surgical Interventions Trials Unit
- Centre for OA Pathogenesis
- Dustin, M Group | Immunological Synapse
- Dustin, L Group | Viral Infection and Immunity
- Luo Group | Statistical genomics and computational immunology
- Monaco Group | Cardiovascular Inflammation
- Nanchahal Group | Treating Fibrosis and Improving Tissue Regeneration
- Sansom Group | Computational and Single Cell Genomics Group
- Pharmaco- and Device epidemiology
- Powrie Group | Mucosal Immunology
- Javaid Group | Rare Bone Diseases and Osteoporosis Epidemiology
- Fritzsche Group | Biophysical Immunology
- Bezbradica Mirkovic Group | Innate Immune Sensing in Inflammation
- Gérard Group | Spatiotemporal Dynamics of T Cell Responses
- Jostins Group | Statistical Genetics of Immune Variation
- Hand Research Group
- Oxford Psoriatic Arthritis Centre (Ox-PACE)
- Clarke Group | Metabolism and Immunity
- Pauklin Group | TGFß signalling in cancer stem cells
- Kennedy Translational Innovation Group
- Dakin Group | Soft Tissue Joint Disease
- Mouthuy Group | Soft Tissue Engineering
- Snelling Group | Soft Tissue Repair
- Stride Group | Biomaterials & Biomechanics
- Biopatch
- Cribbs Group | Computational and Systems Biology
- Feldmann Group | Unravelling the Role of Cytokines in Disease
- Alsaleh Group | Ageing in the musculoskeletal system and beyond earth
- Buckley Group | Stromal Cell Biology
- Progatzky Group | Peripheral glia and immunity
- Planetary Health Informatics
- Theologis Group | Paediatric Orthopaedics
- Johnson Group | Microbiome and Multi-omics
- Fullerton Group | Translational Pharmacology
- Dendrou Group | Immune Disease Multiomics
- Improving Wrist Injury Pathways (I-WIP)
- Hallou Group | Cell and Tissue Dynamics
- Wiberg Group | Peripheral Nerve Research Lab
- Epidemiology and burden of imminent subsequent fractures in postmenopausal women
- Karedla Group | Quantitative Immunodynamics Laboratory
- Health Economics & Outcomes Research
- UK Human Functional Genomics Initiative: Musculoskeletal Cluster
- OTMC Translational Group
- Space Medicine & Research
- Space Medicine & Research
- Day 1 - Monday 16 November 2026
- Day 2 - Tuesday 17 November 2026
- Day 3 - Wednesday 18 November 2026
- Day 4 - Thuesday 19 November 2026
- Day 5 - Friday 20 November 2026
Our publications
Understanding Inflammatory FibRosis in early AdhEsivE CAPsulitis.
What is a frozen shoulder?
Frozen shoulder is a common joint disease affecting 10% of the working population. The condition causes significant shoulder pain, disability and social isolation and predominantly affects patients between 40-60 years old.
Frozen shoulder is poorly understood and currently there are no effective treatments. The joint capsule, an envelope surrounding the shoulder joint becomes inflamed and thickened, causing severe stiffness, which significantly impacts day-to-day life.
Patients typically have symptoms for several years, yet interestingly the condition is self-limiting: it almost always resolves during this time. In contrast many other forms of inflammatory joint disease including arthritis never resolve. Therefore, frozen shoulder is a unique condition whereby chronic inflammation and thickening of the shoulder joint capsule spontaneously resolves over time, as shown in the figure below.
Animal models of frozen shoulder do not accurately represent the condition affecting patients. Access to patient tissue is vital to advance our understanding of disease. In 2020, we established an ethically approved national clinical study called ‘ICECAP’ to collect tissue from the joint capsule of patients undergoing shoulder surgery for advanced stage frozen shoulder. Findings from this study have identified distinct populations of cells in the shoulder joint capsule have become enriched in order to resolve inflammation and fibrosis.
WHAT IS THE FREECAP STUDY?
Understanding Inflammatory Fibrosis in Early Adhesive Capsulitis.
Having identified the biological processes that bring about resolution of disease in advanced-stage frozen shoulder, the focus of this project is to improve understanding of the underlying biological processes occurring in patients with early-stage Frozen Shoulder.
The project will involve collecting a small sample of the capsule which surrounds the shoulder joint from patients who are undergoing planned hydrodilatation of the shoulder capsule as part of their routine clinical care pathway. This tissue will then be studied using cutting edge laboratory techniques to further our understanding of the inflammatory and resolution processes in early stage disease.
Our findings will help to identify more targeted and disease-stage specific treatments for patients suffering from frozen shoulder.
FREECAP STUDY DESIGN
Male and female patients aged between 18-65 years of age are eligible for inclusion to the study. We plan to collect tissues from 20 frozen shoulder patients undergoing planned ultrasound guided hydrodilatation of the shoulder capsule. Patients with shoulder osteoarthritis or disease affecting joints including Rheumatoid Arthritis cannot be included into this study.
Meet the team
|
Chief Investigator |
Dr Rajat Chowdhury Principal Investigator |
Senior Research Nurse and Study Co-Ordinator
|
|
Research Nurse |
Co-Investigator |
|
Contact
01865 737422
FREECAP Study Information
Ethical approval: REC ref 22/PR/1181
Study status: Recruiting